Oral Iron Supplementation for Patients With Chronic Kidney Disease
Status:
Active, not recruiting
Trial end date:
2026-12-30
Target enrollment:
Participant gender:
Summary
The hypothesis of this research is that oral iron prescribed in a single dose in alternate
day could mitigate the side effects with regard to intestinal microbiota, inflammation,
oxidative stress and improve the hematological profile when compared to daily oral iron
prescription